As CFO, Keith is responsible for the integrity of the company’s financial reporting and business control processes while partnering with the leadership team in all aspects of the company’s management including strategy, contracting, investment, operations management and customer satisfaction.
Before joining Lykan, Keith spent 18 months consulting with emerging biotechnology companies as they scaled up operations. Prior to that, he spent six years with Patheon Pharmaceuticals (acquired by Thermo Fisher Scientific). As VP of Finance at Patheon, he supported the global Pharmaceutical Development Services (PDS) business unit and led the initial formation of corporate FP&A and commercial finance. Keith originates from the UK where he qualified as a Chartered Accountant and spent 20 years in hi-tech organizations in Scotland, Switzerland, Germany and the US.
What inspires Keith is seeing teams collaborate and challenge each other to be creative, dynamic and brave as we break down barriers and develop solutions that save lives, one patient at a time. Keith’s daughter was diagnosed with cancer during her junior year of high school making this an even more personal endeavor.